Inflection pivotal as vaccine pump fades

Inflection pivotal as vaccine pump fades

Summary:  With the vaccine pump fizzling, we still remain on alert for a development of more two way price action, particularly within the high flying technology sector.


As we spoke about earlier in the week, the vaccine pump was very much needed given risk sentiment was looking very fatigued. The release of another vaccine breakthrough from Oxford scientists this morning has been met with less vigour than the Moderna hype and the boost to risk appetite is fading fast. This perhaps serves a warning of a resumption of the fading momentum we spoke about earlier this week

As we said yesterday, we look to fade vaccine optimism, and tactically reduce positioning in the technology sector, taking some money off the table in the highflyers. Adding some more cyclical/value exposure, relative to growth/tech/momentum. Given extended growth vs. value positioning and sentiment, there is plenty of opportunity for more two-way price action here – particularly with earnings incoming, of which Netflix will be key tonight. Extended valuations leave little margin for error should the companies disappoint lofty expectations.

The richly valued names that have flown higher, being best positioned for the digitisation/Saas/cloud/e-commerce/online trends that have been accelerated by COVID-19. Alongside lower debt levels, higher free cash flow yields, and earnings duration profiles with high forecast future cash flows in the current interest rate paradigm that allow richer valuations are beginning to stage decent reversals from sharp upwards trends. Nasdaq 100 volatility is also beginning to diverge, alongside Mondays price action and a sequence of higher highs over the prior week on declining volumes, we stand by the tactical positioning we outlined earlier this week. Although we believe the companies leveraged toward these secular growth thematics will outperform in the longrun, valuations and excessively one sided positoning at present make us tactically cautious.

With the reversal in technology stocks and by default momentum/growth comes the potential for a more broad based risk-off move, as momentum works just as easily in the opposite direction.

Complacency reigns for now, but risk builds slowly, and when sentiment shifts, liquidity quickly disappears. Then the previous stability in the seemingly never-ending melt up is destabilizing in itself, with everyone rushing for the exits at once. Particularly following the increased retail and hot money participation chasing momentum in the high-flying stocks, which increases the risk of compulsive selling when sentiment shifts. Long growth/short value positioning is at historical extremes and a reversal in this positioning could be painful, with a correction well overdue.

The key for whether the tactical move is one of profit taking in tech and a rotation toward vlaue/cyclicals OR whether profit taking across some of the high flying momentum names spurs a more broad based risk off move, may well lie with the fate of the USD. As our head of FX strategy John Hardy notes, the USD is at pivotal levels for confirming a real trend in USD weakness, heading into the all important EU Council summit on Friday and Saturday. The risk of a move higher in the USD likely having the capacity to spur sectoral rotation toward more broad risk off. Again, one sided position in EURUSD reveals the risk of disappointment should the recovery package deal prove less of a slam dunk, as has been hinted via the continued resisitance from Austria and the Netherlands.

Quarterly Outlook

01 /

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Trader Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Trader Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Chief Investment Strategist

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992